These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 2628232)

  • 1. [Serum osteocalcin (BGP) as a "marker" of bone mineral content in postmenopausal women].
    Heytmanek G; Metka M; Enzelsberger H; Huber J; Schurz B; Woloszczuk W
    Gynakol Rundsch; 1989; 29(4):245-7. PubMed ID: 2628232
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes of bone formation markers osteocalcin and bone-specific alkaline phosphatase in postmenopausal women with osteoporosis.
    Lumachi F; Ermani M; Camozzi V; Tombolan V; Luisetto G
    Ann N Y Acad Sci; 2009 Sep; 1173 Suppl 1():E60-3. PubMed ID: 19751416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biochemical markers of bone formation in osteoporosis].
    Miki T; Nakatsuka K; Kawakami H; Kosaka H; Nishizawa Y; Morii H
    Rinsho Byori; 1996 May; 44(5):410-4. PubMed ID: 8676558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early, noninvasive diagnostic of osteoporosis in men].
    Lepiarz-Rusek W; Kokocińska D
    Przegl Lek; 2005; 62(7):641-9. PubMed ID: 16463693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common biochemical markers of bone turnover predict future bone loss: a 5-year follow-up study.
    Löfman O; Magnusson P; Toss G; Larsson L
    Clin Chim Acta; 2005 Jun; 356(1-2):67-75. PubMed ID: 15936304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
    Uretmen S; Gol M; Cimrin D; Irmak E
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
    Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
    Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of four biochemical markers of bone metabolism in postmenopausal osteoporosis.
    Majkić-Singh N; Ilić M; Ignjatović S; Aleksandra-Postić-Grujin
    Clin Lab; 2002; 48(7-8):407-13. PubMed ID: 12146575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
    Trento LK; Pietropolli A; Ticconi C; Gravotta E; De Martino MU; Fabbri A; Piccione E
    J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in serum undercarboxylated osteocalcin concentration in bilaterally oophorectomized women.
    Yasui T; Uemura H; Tomita J; Miyatani Y; Yamada M; Kuwahara A; Matsuzaki T; Maegawa M; Miura M; Irahara M
    Maturitas; 2007 Mar; 56(3):288-96. PubMed ID: 17030103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Behavior of selected bio-elements in women with osteoporosis].
    Kotkowiak L
    Ann Acad Med Stetin; 1997; 43():225-38. PubMed ID: 9471918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
    Verit FF; Geyikli I; Yazgan P; Celik A
    Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein.
    Delmas PD; Wahner HW; Mann KG; Riggs BL
    J Lab Clin Med; 1983 Oct; 102(4):470-6. PubMed ID: 6604769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of low bone mineral density and carotid atherosclerosis in postmenopausal women.
    Montalcini T; Emanuele V; Ceravolo R; Gorgone G; Sesti G; Perticone F; Pujia A
    Am J Cardiol; 2004 Jul; 94(2):266-9. PubMed ID: 15246921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of Migu tablet on bone mineral density, serum matrix metalloproteinase-2 level and bone metabolic markers in postmenopausal osteoporosis].
    Dai Y; Shen L
    Zhongguo Zhong Yao Za Zhi; 2007 Nov; 32(22):2409-12. PubMed ID: 18257271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vitamin K2 treatment on carboxylation of osteocalcin in early postmenopausal women.
    Yasui T; Miyatani Y; Tomita J; Yamada M; Uemura H; Miura M; Irahara M
    Gynecol Endocrinol; 2006 Aug; 22(8):455-9. PubMed ID: 17012108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of serum osteocalcin and of the histomorphometric evaluation of iliac biopsy in postmenopausal osteoporosis].
    Delmas PD; Brown JP; Malaval L; Edouard C; Chapuy MC; Meunier PJ
    Rev Rhum Mal Osteoartic; 1984 Nov; 51(10):581-4. PubMed ID: 6335924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum osteocalcin levels in postmenopausal obese women.
    Perfetto F; Tarquini R; Lombardi V; Naldi E; Piluso A; Tarquini B
    Riv Eur Sci Med Farmacol; 1996; 18(2):73-7. PubMed ID: 9177603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic significance of osteocalcin levels in the classification of senile osteoporosis].
    Neradilová M; Soutorová M; Bednár J; Simecková A
    Cas Lek Cesk; 1992 Jan; 131(1):9-11. PubMed ID: 1559253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of sex, age, and menopause in serum osteocalcin (BGP) levels.
    del Pino J; Martín-Gómez E; Martín-Rodríguez M; López-Sosa C; Cordero M; Lanchares JL; García-Talavera JR
    Klin Wochenschr; 1990 Dec; 69(24):1135-8. PubMed ID: 2135297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.